Green Cross Holdings Corporation (KRX:005250)

Market Cap	619.73B -1.1%
Revenue (ttm)	2.45T +11.2%
Net Income	-69.51B
EPS	-1,531.00
Shares Out	45.40M
PE Ratio	n/a
Forward PE	n/a
Dividend	500.00 (3.73%)
Ex-Dividend Date	Mar 30, 2026

Volume	41,182
Average Volume	85,668
Open	13,650
Previous Close	13,650
Day's Range	13,580 - 13,850
52-Week Range	12,000 - 17,700
Beta	0.62
RSI	44.56
Earnings Date	Apr 3, 2026

About Green Cross Holdings

Green Cross Holdings Corporation operates as a biotechnology company. The company provides prescription drugs and over the counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pertussis, tuberculosis, and varicella; recombinant treatments for acquired thrombotic thrombocytopenic purpura, fabry, hemophilia, hunterase, colon cancer...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1967
• Employees: 144
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 005250